【参考文献】 1.Note for Guidance on Quality of Modified Release Products: A: Oral Dosage Forms B: Transdermal Dosage Forms (EMEA,2000) 2. Quality of Prolonged Release Oral Solid Dosage Forms. (EUDRA VOL3A, Q19a ,1992) 3. In Vitro and In vivo Evaluation of Dosage Forms, USP25, 1088-1090. 4. Guidance for Industry ---Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In vivo Correlations. (FDA, 1997). 5. Guidance for the Design and Evaluation of Oral Prolonged Dosage Forms.(Ministry of Health and Welfare, Japan, 1998) 6. 缓控释制剂指导原则,CP2005. 7. In Vitro and In Vivo Evaluation of Dosage Forms, USP25.